Company Profile
Updated: 17-SEP-09Affymax Inc.
Public Company, Headquarters Location
4001 Miranda Ave., Palo Alto, CA 94304-1218, United States
(650)812-8700, (650)424-0832 fax, http://www.affymax.com
Primary SIC: Biological Products Except Diagnostic, Primary NAICS: Biological Product (except Diagnostic) Manufacturing
Description: Manufacturing: Peptides to battle cancer and autoimmune disorders.
View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!
Affymax to Present at Piper Jaffray 21st Annual Healthcare Conference.(Conference news)
Telecommunications Weekly; 12/16/2009; 748 words; Affymax, Inc. (Nasdaq:AFFY) announced that management will present at the...also be available for 30 days following the presentation. About Affymax, Inc. Affymax, Inc. is a biopharmaceutical company committed to developing novel...
Affymax Announces Close of Common Stock Offering and Exercise of Underwriters' Overallotment Option.
Investment Weekly News; 12/12/2009; 894 words; Affymax, Inc. (Nasdaq:AFFY) announced the closing of its underwritten public...under the securities laws of any such state or jurisdiction. About Affymax, Inc. Affymax, Inc. is a biopharmaceutical company committed to developing novel...
FORM 8-K: AFFYMAX ANNOUNCES ENTRY INTO MATERIAL DEFINITIVE AGREEMENT
US Fed News Service, Including US State News; 12/11/2009; 665 words; WASHINGTON, Dec. 10 -- AFFYMAX, INC., Palo Alto, Calif., files Form 8-K (current...Exact name of registrant as specified in its charter is AFFYMAX, INC. State of Incorporation: Delaware Entry into a Material...
Anesiva Announces Prospective Board Members To Be Appointed Upon Successful Completion of Proposed Merger.
Biotech Week; 12/9/2009; 693 words; ...of development at Theravance, Inc. (formerly Advanced Medicine, Inc.). From 1992 to 1998, Dr...product development at Genentech, Inc. Dr. Love also serves as member...directors of Santarus, ARCA and Affymax. Dr. Love holds an M.D...
Affymax Announces Proposed Public Offering of Common Stock.
Investment Weekly News; 12/5/2009; 777 words; Affymax, Inc. (Nasdaq: AFFY), announced that...in an underwritten public offering. Affymax expects to grant the underwriters a thirty...Floor, New York, NY 10020. Keywords: Affymax Inc., Biotechnology, Finance, Health...
Recent News Articles
- OTC Stock Review Stocks in Motion for Thursday, November 19, 2009 are Cyplasin Biomedical Ltd., Salix Pharmaceuticals, Ltd., Affymax Inc., and Delcath Systems, Inc.
M2 Presswire - November 19, 2009 - Analyst Sentiment, Videos, and Trading Data on Affymax, Inc.
M2 Presswire - September 25, 2009 - Affymax Inc - Therapeutic Competitors.
M2 Presswire - June 22, 2009 - Affymax, Inc. at Citi Biotech Day - Final.(Broadcast transcript)
Fair Disclosure Wire - April 01, 2009
Why Purchase This Company Profile?
- Sales prospecting
- Competitive analysis
- Vendor & supplier evaluation
- Customer evaluation and analysis
- Strategic planning